Brokerages expect Liquidia Technologies Inc (NASDAQ:LQDA) to announce earnings of ($0.57) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Liquidia Technologies’ earnings. The highest EPS estimate is ($0.47) and the lowest is ($0.67). The firm is expected to issue its next earnings results on Thursday, August 1st.
According to Zacks, analysts expect that Liquidia Technologies will report full year earnings of ($2.56) per share for the current financial year, with EPS estimates ranging from ($2.83) to ($2.20). For the next fiscal year, analysts forecast that the firm will report earnings of ($2.70) per share, with EPS estimates ranging from ($3.23) to ($2.08). Zacks’ EPS averages are a mean average based on a survey of research firms that cover Liquidia Technologies.
Liquidia Technologies (NASDAQ:LQDA) last announced its quarterly earnings results on Thursday, May 2nd. The company reported ($0.87) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.60) by ($0.27). Liquidia Technologies had a negative net margin of 1,964.76% and a negative return on equity of 222.47%.
A number of institutional investors have recently bought and sold shares of LQDA. Marshall Wace North America L.P. bought a new stake in Liquidia Technologies during the 1st quarter worth approximately $1,881,000. Vanguard Group Inc. purchased a new stake in Liquidia Technologies during the 3rd quarter valued at $4,263,000. OZ Management LP purchased a new stake in Liquidia Technologies during the 1st quarter valued at $1,138,000. Millennium Management LLC boosted its position in Liquidia Technologies by 91.6% during the 4th quarter. Millennium Management LLC now owns 193,277 shares of the company’s stock valued at $4,186,000 after buying an additional 92,399 shares during the period. Finally, Canaan Partners VIII LLC lifted its position in shares of Liquidia Technologies by 1.3% in the 1st quarter. Canaan Partners VIII LLC now owns 2,597,681 shares of the company’s stock worth $29,561,000 after purchasing an additional 34,378 shares during the period. 56.37% of the stock is currently owned by institutional investors and hedge funds.
Shares of LQDA stock traded down $0.42 during trading on Wednesday, reaching $7.96. 43,136 shares of the company’s stock traded hands, compared to its average volume of 89,526. The company has a market capitalization of $155.66 million and a P/E ratio of -1.07. The company has a debt-to-equity ratio of 0.46, a current ratio of 5.57 and a quick ratio of 5.57. The stock has a 50-day moving average price of $9.20. Liquidia Technologies has a 1 year low of $7.88 and a 1 year high of $38.46.
Liquidia Technologies Company Profile
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension.
Featured Article: Quiet Period
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.